UK Markets close in 5 hrs 23 mins

MorphoSys AG (MOR.DE)

XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
15.80-0.18 (-1.13%)
As of 11:52AM CET. Market open.
Full screen
Previous close15.98
Open15.80
Bid15.76 x 1500
Ask15.85 x 8800
Day's range15.65 - 16.05
52-week range13.90 - 36.32
Volume57,846
Avg. volume285,836
Market cap539.428M
Beta (5Y monthly)0.73
PE ratio (TTM)5.32
EPS (TTM)2.97
Earnings date17 Nov 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est32.96
  • EQS Group

    MorphoSys AG: Financial Calendar 2023

    EQS-News: MorphoSys AG / Key word(s): MiscellaneousMorphoSys AG: Financial Calendar 2023 28.11.2022 / 22:03 CET/CESTThe issuer is solely responsible for the content of this announcement.Media ReleasePlanegg/Munich, Germany, November 28, 2022 MorphoSys AG: Financial Calendar 2023 MorphoSys AG (FSE: MOR; NASDAQ: MOR) publishes its financial calendar dates for the year 2023: Publication of Interim Statement / Report Conference Call Year-End Results 2022 March 15, 2023 // 9:00 pm CET (4:00 pm EDT; 8

  • Simply Wall St.

    Earnings Release: Here's Why Analysts Cut Their MorphoSys AG (ETR:MOR) Price Target To €29.30

    Shareholders in MorphoSys AG ( ETR:MOR ) had a terrible week, as shares crashed 26% to €15.50 in the week since its...

  • EQS Group

    MorphoSys AG Reports First Nine Months and Third Quarter 2022 Financial Results

    EQS-News: MorphoSys AG / Key word(s): Quarterly / Interim StatementMorphoSys AG Reports First Nine Months and Third Quarter 2022 Financial Results 16.11.2022 / 22:01 CET/CESTThe issuer is solely responsible for the content of this announcement.Media ReleasePlanegg/Munich, Germany, November 16, 2022 MorphoSys AG Reports First Nine Months and Third Quarter 2022 Financial Results Monjuvi® U.S. net product sales of US$ 22.2 million (€ 21.9 million) for the third quarter of 2022 Presentation of preli